Net profit of Morepen Laboratories rose 17.27% to Rs 40.87 crore in the quarter ended September 2025 as against Rs 34.85 crore during the previous quarter ended September 2024. Sales declined 5.97% to Rs 411.58 crore in the quarter ended September 2025 as against Rs 437.73 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales411.58437.73 -6 OPM %7.4610.07 - PBDT31.1547.88 -35 PBT19.8646.02 -57 NP40.8734.85 17 Powered by Capital Market - Live News

Morepen Laboratories will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live News

Morepen Laboratories has received the rating IVR A-/ Stable for long term bank facilities availed by the company. Powered by Capital Market - Live News

Morepen Laboratories announced that the Annual General Meeting(AGM) of the company will be held on 6 September 2025.Powered by Capital Market - Live News

Net profit of Morepen Laboratories declined 70.28% to Rs 10.75 crore in the quarter ended June 2025 as against Rs 36.17 crore during the previous quarter ended June 2024. Sales declined 6.59% to Rs 425.24 crore in the quarter ended June 2025 as against Rs 455.22 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales425.24455.22 -7 OPM %5.6811.34 - PBDT24.5453.89 -54 PBT15.5248.17 -68 NP10.7536.17 -70 Powered by Capital Market - Live News